Filing Details
- Accession Number:
- 0001363585-13-000016
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-06-20 16:00:16
- Reporting Period:
- 2013-06-18
- Filing Date:
- 2013-06-20
- Accepted Time:
- 2013-06-20 16:00:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1059784 | Generex Biotechnology Corp | GNBT | Pharmaceutical Preparations (2834) | 820490211 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1363585 | Stephen Fellows | 555 Richmond Street West, Po Box 200 Suite 604 Toronto A6 M5V3B1 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-06-18 | 2,524,164 | $0.04 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The shares sold were acquired by the reporting person on June 6, 2013 upon exercise of options to purchase 2,524,164 shares of the issuer's common stock which were granted by the Board of Directors on March 5, 2013 and June 4, 2013 in lieu of cash payment of deferred compensation. The option grants were effective upon the reporting person's execution of Settlement and Release Agreements with the issuer on April 1, 2013 and June 6, 2013, respectively. The option grants were made pursuant to the terms of the issuer's 2006 stock plan.
Billionaire Hedge Funds
